Clinical Trial Update: cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

View source ↗

Summary

A prospective observational validation of a cfDNA assay for early cancer detection and minimal residual disease is currently recruiting across multiple cancer t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Brain Cancer
• Breast Cancer
• Cervical Cancer
• Colorectal Cancer
• Endometrial Cancer
• Esophageal Cancer
• Stomach Cancer

Snippet

Sponsor: Adela, Inc | Conditions: Brain Cancer, Breast Cancer | Status: RECRUITING